Q4 2023 Holdings
Filed 2024-02-14 | 52 holdings | $305.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ishares TR(IWM)Call | RUSSELL 2000 ETF | 464287655 | $50.2M | 250,000 | 16.4% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $26.8M | 300,000 | 8.8% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $22.3M | 250,000 | 7.3% |
| Moonlake Immunotherapeutics(MLTX)Call | CLASS A ORD | 61559X104 | $15.1M | 250,000 | 4.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $13.1M | 165,000 | 4.3% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $11.8M | 275,000 | 3.8% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $9.6M | 100,000 | 3.2% |
| Ambrx Biopharma Inc | COM | 641871108 | $6.8M | 475,000 | 2.2% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $6.7M | 600,000 | 2.2% |
| Cytokinetics Inc(CYTK)Call | COM NEW | 23282W605 | $6.7M | 80,000 | 2.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $6.5M | 300,000 | 2.1% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $6.2M | 50,000 | 2.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $6.1M | 150,000 | 2.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $6.1M | 300,000 | 2.0% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $6.0M | 100,000 | 2.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $5.7M | 15,000 | 1.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $5.3M | 27,500 | 1.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.0M | 125,000 | 1.6% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $4.8M | 80,000 | 1.6% |
| Aerovate Therapeutics Inc | COM | 008064107 | $4.8M | 210,000 | 1.6% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $4.5M | 112,385 | 1.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $4.4M | 70,000 | 1.4% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $4.3M | 250,000 | 1.4% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $3.8M | 165,000 | 1.2% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $3.7M | 2,100,000 | 1.2% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $3.6M | 225,000 | 1.2% |
| Savara Inc(SVRA) | COM | 805111101 | $3.5M | 750,000 | 1.2% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $3.5M | 385,241 | 1.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $3.5M | 15,000 | 1.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $3.4M | 150,000 | 1.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $3.4M | 400,000 | 1.1% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $3.3M | 375,000 | 1.1% |
| Amylyx Pharmaceuticals Inc(AMLX)Call | COM | 03237H101 | $2.9M | 200,000 | 1.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $2.9M | 125,000 | 0.9% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $2.6M | 335,000 | 0.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $2.5M | 20,000 | 0.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $2.4M | 59,250 | 0.8% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $2.3M | 65,000 | 0.8% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $2.2M | 725,000 | 0.7% |
| Natera Inc(NTRA) | COM | 632307104 | $2.2M | 35,000 | 0.7% |
| Revolution Medicines Inc(RVMD)Put | COM | 76155X100 | $2.2M | 75,000 | 0.7% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $2.1M | 90,000 | 0.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.6M | 130,036 | 0.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.6M | 50,000 | 0.5% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $1.5M | 135,000 | 0.5% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $1.3M | 35,000 | 0.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $1.1M | 195,000 | 0.4% |
| Uniqure NV(QURE) | SHS | N90064101 | $1.1M | 165,000 | 0.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $834.9K | 10,000 | 0.3% |
| Perspective Therapeutics Inc | COM | 46489V104 | $643.2K | 1,600,000 | 0.2% |